INTRODUCTION
============

The functional interplay between lectins and their "self" or "non-self" carbohydrate receptors implicated in various aspects of immune responses of both vertebrates and invertebrates have been characterized in considerable detail in recent years ([@B7]; [@B64]; [@B69]). It is now firmly established C-type lectins, ficolins, siglecs, and galectins are not only key players in innate immune processes that lead to pathogen recognition, endocytosis, complement activation, and antigen processing, but are also involved in adaptive immune functions, including B and T cell clonal selection, maturation, activation, and apoptosis. In addition, lectins also participate in other intracellular and extracellular biological processes such as glycoprotein trafficking, protein folding, cell--cell or cell--ECM interactions, signal transduction, fertilization, and development (reviewed in [@B126]). The identification of strikingly diverse lectin repertoires in virtually every animal species, including the presence of multiple lectin families with numerous members and lectin isoforms, has enabled rationalization of their roles in immunity. Unlike immunoglobulins, however, lectins do not generate diversity in recognition by genetic recombination and therefore, considerable interest has arisen on the germline-encoded diversity of the lectin repertoires, the somatic mechanisms leading to expansion of their ligand recognition spectrum, and the structural/functional aspects their carbohydrate recognition domains (CRDs; [@B130]; [@B41]).

It is now firmly established that in vertebrates innate immunity carries a substantial burden of the defense functions against infections disease, and in the past few years the instructive roles of innate immunity on adaptive immunity have been widely recognized. Furthermore, invertebrates and protochordates rely solely on innate immunity for defense against microbial infection. Thus, great interest has been generated in the structural-functional aspects of its various components, particularly on complement, lectins, and Toll-like receptors ([@B37]; [@B56]; [@B54]). Both the *Drosophila* Toll and the mammalian Toll-like receptors recognize pathogens via highly conserved and widely distributed microbial surface molecules such as lipopolysaccharide, flagellin, lipoteichoic acid, or peptidoglycan ("pathogen-associated molecular patterns"; PAMPs), which are essential for the microbe but absent in the host. By recognizing such non-self molecular patterns, these receptors were designated as "pattern recognition receptors" (PRRs; [@B75]). Given that non-pathogenic microbes also share these surface molecules it has been suggested that these may be more accurately described as "microbe-associated molecular patterns" (MAMPs; [@B12]). More recently, the term "virulence-associated molecular pattern" (VAMP) has been introduced to describe those factors (e.g., microbial toxins, flagellin) that enable the host to discriminate pathogenic microbes from the non-pathogenic ones ([@B77]). Finally, endogenous factors such as nuclear or cytosolic components that are released during tissue stress or necrosis can trigger inflammatory responses have been designated as "danger-associated molecular patterns" (DAMPs; [@B110]).

THE MANNOSE-BINDING LECTIN AS A PROTOTYPICAL PATTERN RECOGNITION RECEPTOR
=========================================================================

Since the PRR/PAMP paradigm was initially established for Toll and TLRs, it has been progressively extended to other innate immune recognition proteins. Among the best-characterized animal lectins, the mannose-binding lectin (MBL) a member of the C-type lectin family has been described as a prototypical PRR ([@B41]). C-type lectins are characterized by their Ca^2+^ requirement for ligand binding and their structural fold (C-type lectin domain fold, CTLD), and in most family members, the presence of multiple, unrelated structural domains in the polypeptide ([@B141]). They comprise the collectins (MBLs, ficolin, conglutinin, pulmonary surfactant), proteoglycan core proteins, selectins, endocytic receptors, the mannose-macrophage receptor, and DC-SIGN ([@B141]; [@B55]). Although some C-type lectins such as selectins and DC-SIGN bind "self" glycans, others such as collectins recognize exposed sugar ligands on the microbial surface. Collectins are lectins with a collagenous region linked to the CRD that recognizes sugars on microbial surfaces, and upon binding to a serine protease (MBL-associated serine proteases; MASPs) may activate the complement cascade ([@B139]; [@B134]; [@B81]; [@B57]; **Figure [1](#F1){ref-type="fig"}**). Several lectins homologous of MBLs and ficolins, MASPs, and complement components have been identified in invertebrates and ectothermic vertebrates, suggesting that C-type lectins and the complement system played a pivotal role in innate immunity long before the emergence of adaptive immunity in vertebrates ([@B139]; [@B134]; [@B81]). The CTLD fold has a double-loop structure with its N- and C-terminal β strands (β1, β5) coming close together to form an antiparallel β-sheet (**Figure [1A](#F1){ref-type="fig"}**). The second loop that lies within the domain is long and it enters and exits the core domain at the same location. Four cysteine residues (C1--C4), the most conserved residues in the CTLD, form disulfide bridges at the bases of the loops. The residues C1 and C4 link β5 and α1 (the whole domain loop), while C2 and C3 residues link β3 and β5 (the long loop region). The rest of the chain contains two flanking α helices (α1 and α2) and the second β-sheet, formed by strands β2, β3, and β4 ([@B139]; [@B35]; [@B66]). The long loop region is involved in Ca^2+^-dependent carbohydrate binding, and in domain-swapping dimerization of some CTLDs. Four Ca^2+^-binding sites are present in the CTLD structures, of which only one (site 2) is known to participate in binding to the carbohydrate ligand ([@B68]; [@B138]; [@B35]). Resolution of the structure of the rat MBP-A/Man~6~-GalNAc~2~-Asn complex revealed that a ternary complex is formed between the protein, the Ca^2+^ ion bound in site 2, and the terminal mannose moiety of the oligosaccharide ([@B137]). The complex is stabilized by a network of coordination and hydrogen bonds: oxygen atoms from 4- and 3-hydroxyls of the mannose form two coordination bonds with the Ca^2+^ ion and four hydrogen bonds with the carbonyl side chains that form the Ca^2+^-binding site 2 (**Figure [1B](#F1){ref-type="fig"}**). The amino acid residues flanking the conserved *cis-*proline in the long loop region, which are involved in Ca^2+^-binding site 2 formation, determine the specificity for either galactose or mannose (**Figure [1C](#F1){ref-type="fig"}**). In most mannose-binding CTLDs, the sequence of the motif is EPN (E^185^ and N^185^ in MBP-A), while in the galactose-specific CTLDs it is QPD. The oligomerization of the MBL subunits results in binding multivalency that enables the protein to recognize ligands that are displayed 45 Å apart on the microbial surface, thereby increasing the MBL's avidity (**Figure [1D](#F1){ref-type="fig"}**). The density of the surface ligands and their scaffolding (as glycoproteins or glycolipids) modulates affinity of the interaction via negative cooperativity ([@B26]). Thus, the binding of MBL to multiple non-reducing terminal carbohydrate ligands on the microbial surface, which are not readily exposed in the mammalian host, leads to agglutination and immobilization of the potential pathogen. Further, the interactions of other MBL domains with additional factors such as the MASP trigger downstream effector functions including complement activation and opsonization or lysis of the agglutinated microbes ([@B139]; [@B81]). In addition to C-type lectins, other lectins families have been identified as PRRs, including ficolins, F-lectins, pentraxins, and more recently, the galectins (reviewed in [@B126]).

![**Recognition and effector activities of the mannose-binding lectin (MBL). (A)** A schematic representation of CTLD organization; (**B**) Crystallographic model of CTLD; (**C**) Ca^2+^-dependent carbohydrate binding of CTLD. The CRD recognizes equatorial hydroxyls on C3 and C4 of non-reducing terminal mannose with participation of the Ca^2+^ atom. (**D**) The MBL trimer binds to ligands that are displayed about 45 Å apart on the microbial surface, and via association with the MASP) may activate the complement cascade, leading to opsonization or lysis of the microbe.](fimmu-03-00199-g001){#F1}

GALECTINS: A STRUCTURALLY CONSERVED LECTIN FAMILY
=================================================

Galectins constitute a family of animal lectins defined by their affinity for β-galactosides, and a characteristic CRD sequence motif ([@B24]). The galectin family members are widely distributed in eukaryotic taxa from fungi and sponges to both protostome and deuterostome lineages of metazoans and from the structural standpoint are strikingly conserved ([@B129]; [@B24]). Based on their domain organization, galectins have been classified in three types: "proto," "chimera," and "tandem-repeat" ([@B48]; **Figure [2A](#F2){ref-type="fig"}**). Proto-type galectins contain one CRD per subunit and are non-covalently linked homodimers. The chimera galectins have a C-terminal CRD and an N-terminal domain rich in proline and glycine. In tandem-repeat (TR) galectins, two CRDs are joined by a functional linker peptide. Recently, a novel TR-type galectin with four CRDs has been described ([@B121]). Proto and TR types comprise several distinct galectin subtypes, which have been numbered following the order of their discovery. At present time, 15 galectin subtypes have been identified in mammals. Galectin-1, -2, -5, -7, -10, -11, -13, -14, and -15 are proto type. Galectin-3 is the only chimera type. Galectin-4, -6, -8, -9, and -12 are TR type. In solution, galectins can form multivalent species in a concentration-dependent equilibrium ([@B78]). The association of proto-type galectin monomers as non-covalently bound dimers via a hydrophobic interphase is critical for their function in mediating cell--cell or cell--ECM interactions, lattice formation at the cell surface, and downstream effector functions ([@B97]). For the chimera-type galectins, oligomerization takes place via the N-terminus domain to form trimers or pentamers that in the presence of multivalent oligosaccharides in solution or at the cell surface display binding cooperativity ([@B13]; [@B97]; [@B26]). Proto-type galectins associate as non-covalently bound dimers via a hydrophobic interphase, while the bivalent TR-type galectins can recognize different saccharide ligands with a single polypeptide, although they can also form higher order aggregates that enhances their avidity ([@B65]; [@B123]). Most galectins are non-glycosylated soluble proteins, although a few exceptions have transmembrane domains ([@B43]; [@B62]). Although galectins lack a typical secretion signal peptide, they are present not only in the cytosol and the nucleus, but also in the extracellular space ([@B19]). From the cytosol, galectins may be targeted for secretion by non-classical mechanisms, possibly by direct translocation across the plasma membrane ([@B105]; [@B20]; [@B133]). In the extracellular space, galectins can bind to glycans at the cell surface and/or the extracellular matrix ([@B33]; [@B98]) and to potential pathogens ([@B76]; [@B125]). Galectins preferentially bind to *N*-acetyllactosamine (LacNAc; Galβ1,4GlcNAc) and related disaccharides, including lactose (Lac), T-disaccharide (Galβ1,3GalNAc), and human ABH blood group oligosaccharides. Thus, glycans that contain *N*-acetyllactosamine and polylactosamine chains \[(Galβ1,4GlcNAc)n\], such as laminin, fibronectin, lysosome-associated membrane proteins, and mucins, are the preferred endogenous glycans recognized by galectins ([@B34]; [@B109]). The biological function of a particular galectin, however, may vary from site to site, depending on the availability of suitable ligands. The binding properties and biological functions of galectins in the oxidative extracellular environment, however, may depend on their immediate binding to ligand, which prevents the oxidation of free cysteine residues, as well as galectin susceptibility to proteolysis ([@B67]; [@B61]). The binding of galectins to cell surface β-galactoside-containing glycolipids and glycoproteins can lead to the formation of lattices that cluster these ligands into lipid raft microdomains required for optimal transmission of signals relevant to cell function ([@B13]; [@B88]; [@B99]; (**Figures [2B](#F2){ref-type="fig"}** and [C](#F2){ref-type="fig"}). Galectin-mediated lipid raft assembly may modulate turnover of endocytic receptors, signal transduction pathways leading to T cell activation and cytokine secretion, or apoptosis, B cell maturation, activation and tolerance, and neutrophil activation leading to phagocytosis, oxidative burst, and protease and cytokine release. Thus, galectin-glycoprotein lattices at the cell surface have been proposed to function as an "on-an-off switch" that regulates cell proliferation, differentiation and survival, including immune cell responsiveness and tolerance ([@B13]; [@B26]).

![**Galectin recognition. (A)** Schematic representation of galectin domain organization; (**B**) Schematic illustration of *cis*-interactions of proto, chimera, and tandem repeat galectins with host cell surface glycans. (**C**) Schematic illustration of *trans*-interactions of proto, chimera, and tandem repeat galectins with host cell surface and microbial glycans. Proto- and trandem repeat-type galectins can cross-link host and microbial glycans. Chimera galectins (galectin-3) can recognize microbial glycans but it is not clear that they can cross-link them to the host cell surface.](fimmu-03-00199-g002){#F2}

Among mammalian galectins, gene organization and primary structures of the encoded proteins are substantially conserved (**Figure [3A](#F3){ref-type="fig"}**). Prior to or during early in chordate evolution, duplication of a mono-CRD galectin gene would have led to a bi-CRD galectin gene, in which the N- and C-terminal CRDs subsequently diverged into two different subtypes, defined by exon--intron structure (F4-CRD and F3-CRD). All vertebrate single-CRD galectins belong to either the F3 (e.g., gal-1, -2, -3, -5) or F4 (e.g., gal-7, -10, -13, -14) subtype, whereas TR galectins such as gal-4, -6, -8, -9, and -12 contain both F4 and F3 subtypes ([@B49]). However, phylogenetic analysis of the galectin (CvGal) from the eastern oyster *Crassostrea virginica*, that displays four tandemly arrayed CRDs, revealed that these are closely related to the single CRD galectins, suggesting that the CvGal gene is the product of two consecutive gene duplications of a single-CRD galectin gene ([@B121]; **Figure [3B](#F3){ref-type="fig"}**). Like for C- and F-type lectins, most mammals are endowed with a complex galectin repertoire, including members that exhibit multiple isoforms and more or less subtle variations in carbohydrate specificity, which together with a certain degree of plasticity in sugar binding of each CRD, suggests a substantial diversity in recognition properties ([@B115]; [@B142]; [@B104]; [@B34]; [@B2]; [@B114]). In general, ectothermic vertebrates and invertebrates, and earlier taxa such as parazoa (sponges), fungi, and protista appear to have a smaller galectin repertoire. The presence of a galectin fold in the protistan parasite *Toxoplasma gondii*, and galectin-like proteins in the fungus *Coprinopsis cinerea* and in the sponge *Geodia cydonium* reveals the early emergence and structural conservation of galectins in eukaryotic evolution ([@B102]; [@B136]; [@B116]). Among the ectothermic vertebrates, proto-type galectins have been characterized in toads (*Bufo arenarum*), frogs (*Rana catesbeiana*, *Xenopus laevis*), salamanders (*Ambystoma mexicanum*), and zebrafish, among numerous other species ([@B4], [@B3]; [@B127]; [@B24]; [@B114]). The proto-type galectin from *B. arenarum* resembles the mammalian galectin-1 with respect to its carbohydrate-binding profiles and its carbohydrate-binding sequence motif (all nine residues responsible for carbohydrate binding are present: His45, Asn47, Arg49, His53, Asp55, Asn62, Trp69, Glu72, and Arg74; [@B4]). The structures of the *B. arenarum* galectin complexed with LacNAc or TDG further support this close similarity ([@B9]). Multiple proto-type galectins from *X. laevis* and zebrafish contain all the above nine amino acid residues for carbohydrate binding, and are likely to exhibit a binding profile similar to the mammalian galectin-1. Some divergent family members exhibit unique features, ranging from sequence replacements in the CRD to major structural differences. In a proto galectin from *X. laevis*, His52 and Arg73 (numbered as the bovine galectin-1) are replaced by Ser and Lys, respectively ([@B71]; [@B114]), leading to a distinct sugar-binding profile ([@B71]; [@B5]). In congerin I, a galectin from the conger eel*Conger myriaster*, one of the β strands is exchanged between the two subunits ([@B112], [@B111]). This "strand-swap" contributes to stabilize the dimer by increasing inter-subunit interactions, and perhaps explains the high thermostability of the protein. CGL2, a galectin from the fungus *Coprinus cinereus*forms a tetramer characterized by two perpendicular twofold axes of rotation, with the C-terminal amino acids of the four monomers meeting at the center of the tetramer interface ([@B135]). Furthermore, some galectin-like proteins such as the mammalian lens crystalline protein GRIFIN (galectin-related inter-fiber protein) and the galectin-related protein GRP (previously HSPC159; hematopoietic stem cell precursor) lack carbohydrate-binding activity, and are considered products of evolutionary co-option ([@B82]; [@B6]).

![**Gene organization and phylogeny of galectins. (A)** Genomic structures of galectin-1 or galectin-1 like protein from human, murine, chicken, and zebrafish (*Danio rerio*). Coding sequences (exons) are represented by boxes, with their sizes noted above each box. Intron sizes are shown below. (**B**) Phylogenetic analysis of invertebrate galectins modified based on [@B121]. The unrooted tree constructed by the N-J distance method is shown.](fimmu-03-00199-g003){#F3}

Resolution of the structure of galectin-1--LacNAc complex revealed a jellyroll topology typical of legume lectins, and enabled the identification of the amino acid residues and the hydroxyl groups of the ligands that participate in protein--carbohydrate interactions ([@B67]; [@B61]; [@B9]). The subunit of galectin-1 is composed of an 11-strand antiparallel β-sandwich and contains a single CRD (**Figure [4A](#F4){ref-type="fig"}**). The carbohydrate binding site is formed by three continuous concave strands (β4--β6) containing all important residues such as histidine 44, asparagine 46, arginine 48, histidine 52, asparagine 61, tryptophan 68, glutamic acid 71, and arginine 730 that are involved in direct interactions with LacNAc ([@B61]; **Figure [4B](#F4){ref-type="fig"}**). Additional interactions of water molecules are involved in bridging the nitrogen of the NAc group with His52, Asp54, and Arg73 resulting in the increased affinity of LacNAc over Lac. Unlike galectin-1, galectin-3 has an extended carbohydrate-binding site formed by a cleft open at both ends, in which the LacNAc is positioned in such a way that the reducing end of the LacNAc (GlcNAc) is open to solvent, but the non-reducing Gal moiety is in close proximity to residues in the β3 strand ([@B109]). The extended binding site leads to increased affinity for glycans with multiple lactosamine units, and with their substitution of the non-reducing terminal galactose moiety such as ABH blood group oligosaccharides \[Fucα1, 2; GalNAcα1,3(Fucα1,2); and Galα1,3(Fucα1,2)\]. Thermodynamic approaches have been used not only to assess the galectins' carbohydrate-binding properties, but also the oligomeric organization of the protein. On microcalorimetric studies, the dissociation constants for the interactions of bovine galectin-1 with the preferred ligands (lactose, *N*-acetyllactosamine, thiodigalactoside) were in the range of 10^-5^ M, with two binding sites per molecule ([@B108]).

![**Structures of bovine galectin-1 and *Bufo arenarum* galectin-1 like protein. (A)** The ribbon diagram shows the overlap of the toad (*B. arenarum*) galectin-1 like protein (blue, PDB 1GAN) and bovine (*Bos taurus*) galectin-1 (yellow, PDB 1slt) in complex with LacNAc (stick representation). (**B**) Carbohydrate-binding sites of *B. arenarum* galectin-1 like protein (blue) and bovine galectin-1 (yellow). The interactions of amino acid residues with LacNAc are shown for the bovine galectin-1. The OH at C4' of Gal (in LacNAc) makes hydrogen bond interactions with the highly conserved residues His44, Asn46, and Arg48. The OH at C6' makes similar interactions with the Asn61 and Glu71. Trp68 participates in a stacking interaction with the Gal ring carbons and restricts orientation of the OH at C4' to the axial form. In GlcNAc moiety of the LacNAc, the hydrogen bond interactions are involved with the protein through the C3-OH with Agr48, Glu71, and Arg73. Additional interactions are involved via a water molecule that bridges the nitrogen of the NAc group with His52, Asp54, and Arg73. (**C**) *Drgal*1-L2 (green**)** was modeled at the SWISS-MODEL Protein Modeling Server (<http://swissmodel.expasy.org>) based on the bovine galectin-1 structure (yellow, PDB 1slt). All nine residues that form the carbohydrate-binding cassette in mammalian galectin-1 are present in the putative binding site of *Drgal*1-L2. All side chains of these residues were within 0.5 Å of the equivalent side chains of the bovine galectin-1. (**D**) *C. elegans* 16-kDa galectin (Lec-6; shown in green) was modeled at the SWISS-MODEL Protein Modeling Server (<http://swissmodel.expasy.org>) based on the bovine galectin-1 structure (shown in yellow, PDB 1slt). The model reveals that a shorter loop (indicated by arrow) between strands 4 and 5 is responsible for its unique binding profile. (**E**) Alignment of bovine galectin-1, Ce16 (C. *elegans* 16 kDa galectin), and CRD1 to -4 of CvGal. (**F**) Homology modeling of CvGal CRDs. Bovine galectin-1, CRD-1, -2, -3, and -4 are shown in white, blue, yellow, red, and green, respectively. Numbering of amino acid residues is based on bovine galectin-1.](fimmu-03-00199-g004){#F4}

The galectin-1 like protein (Drgal-L2) from zebrafish (*Danio rerio*) shows extensive sequence homology and structural similarity to vertebrate galectin-1 (**Figure [4C](#F4){ref-type="fig"}**). All nine residues that form the carbohydrate-binding cassette in the mammalian galectin-1 are present in the putative binding site of Drgal1-L2 ([@B2]). All side chains of these residues were within 0.5 Å of the equivalent side chains of the bovine galectin-1. Although, the model of the *Caenorhabditis elegans* 16-kDa galectin (Ce16) is similar to the bovine galectin-1 structure (**Figure [4D](#F4){ref-type="fig"}**), the carbohydrate specificity of the Ce16 is interesting compared to the bovine galectin-1 ([@B2]). In Ce16, amino acid substitutions at positions 46 and 48 (29 and 31 in bovine galectin) suggest that unlike in bovine galectin-1, these positions (strand 3) are involved in sugar binding. R^46^ (S^29^ in the bovine galectin sequence) interacts with 3′- and 4′-OH of the Gal residue. Interestingly, a shorter loop 2 (containing residues 66--69 between strands 4 and 5; **Figure [4E](#F4){ref-type="fig"}**) allows E^67^ to interact with equatorial -OH at C-3 of GlcNAc (in Galβ1,4GlcNAc) as well as axial -OH at C-4 of GalNAc (in Galβ1,3GalNAc). The model of the binding site of the *C. elegans* 16-kDa galectin also provides a rationale for the binding to α and β derivatives of Galβ1,3GalNAc ([@B2]). The sequence alignment of the oyster *Crassostrea virginica* galectin CvGal with the bovine galectin-1 revealed that among nine aa residues responsible for ligand binding, seven are conserved in all four CvGal CRDs (His^44^, Asn^46^, Arg^48^, Asn^61^, Trp^68^, Glu^71^, and Arg^73^; numbers corresponding to the bovine galectin-1; [@B121]; **Figure [4E](#F4){ref-type="fig"}**). Homology modeling of all four CvGal CRDs revealed that the seven conserved residues from all four CvGal CRDs maintain their positions and orientations in the binding cleft, relative to the bovine galectin-1 (**Figure [4F](#F4){ref-type="fig"}**).

Although relatively conserved from a structural standpoint, galectins display a surprising functional diversification (**Figure [5](#F5){ref-type="fig"}**). Proto-type galectins such as galectin-1 have been reported as mediators of cell adhesion ([@B139]; [@B134]), B cell differentiation ([@B46]; [@B73]), development ([@B92]), inflammation ([@B101]), mRNA splicing ([@B89]), leukocyte apoptosis ([@B90]; [@B95]), neutrophil turnover ([@B31]), and cancer metastasis ([@B120]; [@B64]). Furthermore, given the complexity of the mammalian galectin repertoire and the initial difficulties in identifying clear phenotypes in null mice for selected galectin family members, it was believed that a certain degree of functional redundancy exists among the members of the galectin repertoire. More recently, however, as the subtle aspects of their binding properties and natural ligands are identified and characterized, and their biological roles are elucidated in increasing detail, it has become clear that this is not the case ([@B98]). Soon after their discovery, galectins were characterized as developmentally regulated proteins, and proposed to participate in embryogenesis and early development. This was based on their binding to "self" carbohydrate moieties, such as polylactosamine-containing glycans, abundant at the cell surface and the ECM (**Figure [5](#F5){ref-type="fig"}**). Chicken galectins have been proposed to participate in myoblast fusion, whereas murine galectin-1 and galectin-3 have roles in notochord development, somitogenesis, and development of muscle tissue and central nervous system ([@B93]; [@B21]; [@B94]; [@B113]).

![Expression, secretion, and functional diversification of galectins: (**1**) Galectin transcripts are translated in the cytoplasm, and the proteins can be translocated into the nucleus (**2**) where they can associate with ribonucleoproteins. *Via* unconventional mechanism(s), galectins can be secreted to the extracellular space (**3**) where they can function as pattern recognition receptors for microbial glycans (**4**), bind to the host cell surface glycans (**5**), and cross-link them with ECM glycans (**6**) thereby, for example, promoting cell migration. Galectins can also cross-link cell surface glycans and induce clustering of microdomains and lattice formation at the cell surface (**7**) that can trigger signaling cascades, or cross-link neighboring cells (**8**) and promote cell--cell interactions/adhesion.](fimmu-03-00199-g005){#F5}

Recent studies show that the gene encoding human galectin-2, a close relative of galectin-1, is mutated in patients with increased susceptibility to myocardial infarction, implicating galectin functions in vascular inflammation and atherosclerosis ([@B87]). Further, expression of galectin-3 at the onset of chondrification suggests its role in bone development, which was supported by finding of abnormalities of the hypertrophic zones of cells and a reduction of the total hypertrophic chondrocytes in galectin-3 null mice ([@B22]).

GALECTINS AS REGULATORS OF IMMUNE HOMEOSTASIS
=============================================

It is now firmly established that galectins participate in both innate and adaptive immune responses ([@B70]; [@B103]; [@B15]; [@B83]; [@B72]; [@B74]). Galectins are ubiquitously expressed and distributed in mammalian tissues, including most cells of the innate (dendritic cells (DCs), macrophages, mast cells, natural killer cells, gamma/delta T cells, and B-1 cells) and adaptive (activated B and T cells) immune system, and as in other cell types ([@B60]; [@B17]).

Since the early 1990s a growing body of experimental (*in vivo* and *in vitro*) evidence has accumulated to support the roles of galectins expressed by these cells and neighboring stromal cells in the development and regulation of innate and adaptive immune homeostasis as well as responses to infectious and allergic challenge, and cancer. Galectins released by stromal cells in central compartments contribute to the differentiation of immune cell precursors. Immune challenge and several pathological conditions may lead to further activation and differentiation of immune cells, and modulate the expression and release of galectins to the extracellular space where they may have autocrine or paracrine effects on immune regulation. Galectins released by immune cells can oligomerize and form lattices at the cell surface leading to activation of transmembrane signaling pathways that modulate immune cell functions, including for example, cell adhesion and migration, T cell apoptosis, and the Th1/Th2 cytokine balance ([@B98]). Further, galectins released into the extracellular environment under abnormal situations may themselves constitute "danger signals," or by exerting their activities on other cells, such as mast cells, induce degranulation and release of factors (e.g., histamine) that represent the "danger signals" leading to activation of immune mechanisms in the absence of antigenic challenge ([@B106]).

Galectins have diverse effects on cells involved in innate immune responses ([@B96]; [@B30]) including macrophages and DCs, neutrophils, eosinophils, and mast cells. Galectin-1 participates in acute and allergic inflammation and displays anti-inflammatory activities by blocking or attenuating signaling events that lead to leukocyte infiltration, migration, and recruitment ([@B45]). It also displays various other effects on innate immunity, including cell surface exposure of phosphatidylserine in activated neutrophils, a process that leads to neutrophil removal by phagocytic cells without causing apoptosis, and activation/deactivation of macrophages on a concentration-dependent manner. In contrast to the anti-inflammatory effects of galectin-1, galectin-3 shows pro-inflammatory activity. Galectin-3 is normally expressed in various epithelia and inflammatory cells, such as activated macrophages, DCs, and Kupffer cells, and is upregulated during inflammation, cell proliferation, and cell differentiation. Galectin-3 also exhibits anti-apoptotic activity for macrophages and enhances their interactions with basal lamina glycans, such as laminin and fibronectin. Taken together, these observations strongly suggest that galectin-3 enhances macrophage survival, and positively modulates their recruitment and anti-microbial activity. Galectin-9 is a selective chemoattractant for eosinophils, highly expressed in various tissues of the immune system, such as bone marrow, spleen, thymus, and lymph nodes. Gal-9 released from activated T cells induces chemotaxis, activation, oxidative activity, and degranulation of eosinophils, and monocyte-derived DC maturation ([@B88]; [@B84]; [@B99]; [@B119]). Galectin-9 also promotes tissue inflammation through interaction with TIM-3 on macrophages ([@B8]; [@B30]).

Concerning adaptive immune responses galectins function as regulators of immune cell homeostasis ([@B15]; [@B96]; [@B53]; [@B30]). Interactions between stromal cells from the bone marrow and thymic compartments and lymphocyte precursors are critical to their development, selection, and further progression to the periphery. In this regard, interactions mediated by galectins can modulate B cell maturation and differentiation both at the central and peripheral immune compartments ([@B96]). Similarly, from their early developmental stages in the thymic compartment to the removal of the mature activated T cells in the periphery, the regulation of T cell survival is critical to a controlled immune response. Galectin-1 can regulate T cell proliferation and apoptosis through binding and clustering of lactosamine-rich cell surface glycoconjugates into segregated membrane microdomains ([@B98]). Galectin-1 may have pro- or anti-apoptotic effects on T cells depending on the developmental stage and activation status of the cell, and the microenvironment in which the exposure takes place. An immunoregulatory circuit involving galectin-1, DCs, and T cells has recently been described by Rabinovich and his associates ([@B53]). Upon exposure to galectin-1, DCs acquired an IL-27-dependent regulatory function and promoted IL-10-mediated T cell tolerance, Th1, and Th17 responses, and suppressed autoimmune neuroinflammation ([@B53]). Effects of galectin-3 in T cell survival are dependent on whether protein is produced endogenously (anti-apoptotic) or by exogenous exposure (pro-apoptotic; [@B114]). Several studies suggest that intracellular galectin-3 confers resistance to apoptosis in response to chemotherapeutic drugs ([@B38]). In contrast, extracellular galectin-3 has been shown to induce T cell apoptosis through caspase-3 activation ([@B39]). Galectin-3 can also modulate T cell activation. Recent studies demonstrated that endogenous galectin-3 can directly control T cell activation at sites of immunological synapse ([@B18]).

Galectins also exert regulatory functions in T cell homeostasis, and signaling cascades triggered by their binding and lattice formation at the T cell surface has implications in a variety of downstream events that modulate their differentiation, functional activation, and production of pro- and anti-inflammatory cytokines. The effects of galectins on T cell cytokine synthesis and secretion ultimately determine the Th1/Th2 polarization of the immune response. By reducing IFN-γ and IL-2 and enhancing IL-5, IL-10, and TGF-β production, galectin-1 skews the balance from a Th1- toward a Th2-polarized response, whereas by reducing IL-5 levels, galectin-3 drives have the opposite effect ([@B63]). Finally, given the regulatory roles of galectins on cells that mediate both innate and adaptive immune responses, their effects can be beneficial or detrimental to pathological conditions that have a basis on exacerbated or depressed immune function, such as inflammatory, allergic, and autoimmune disorders, and cancer ([@B63]).

GALECTINS AS PATTERN RECOGNITION RECEPTORS
==========================================

Insight into the multiple roles of galectins in both innate and adaptive immune functions has further expanded recently by discovery of their ability to directly recognize microbial pathogens ([@B70]), a property shared with other lectin types, such as C- and F-lectins, ficolins, and pentraxins. The roles of lectins in recognition of microbial glycans are particularly critical in invertebrates, since these organisms lack immunoglobulins and rely solely in innate immune mechanisms for recognition of potential microbial pathogens ([@B42]). This seems to be the case even in vertebrate taxa, since it has been reported that susceptibility/resistance to several infectious diseases in humans are determined by the presence of certain lectin alleles ([@B40]). As discussed above, recognition of "non-self" carbohydrate moieties on the surface of microbial pathogens and parasites by lectins such as the MBL can be rationalized under the PRR/PAMP concept. In contrast, for those lectins that recognize endogenous glycans such as galectins, understanding recognition of microbial glycans requires additional considerations. In some cases, the ligands on foreign cells can be similar to those displayed on host cells such as ABH or Le blood group oligosaccharides ([@B15]; [@B117]) and LacNAc present in viral and bacterial glycans, or structurally different and absent from the host glycome, such as α1-2-mannans in*Candida*([@B23]) and LacdiNAc in *Schistosoma*([@B25]). While the first scenario can be conceptualized as molecular mimicry by the microbial pathogens ([@B125]), understanding the molecular basis of galectin binding to distinct self and non-self glycans via the same CRD requires further discussion. In this regard, galectins with tandemly arrayed CRDs such as the TR galectins from vertebrates, and the 4-CRD galectins from invertebrates are intriguing both in their binding properties and functional aspects. Vertebrate TR galectins such as galectin-4, -8, and -9 differ from the proto and chimera types in that they display two tandemly arrayed CRDs, and like the binary CRD F-type lectins, the N- and C-CRDs of TR galectins are similar but not identical, suggesting that they have distinct recognition properties ([@B14]). The structures of the TR galectin-4, -8, and -9 have been partially resolved either by crystallization of NMR analysis of their isolated N- or C-CRDs and revealed differences in their binding specificity and/or affinity for oligosaccharides or their scaffolding as glycolipids or glycoproteins ([@B122]; [@B80]; [@B59]). The structure of the N-CRD of the mouse galectin-4 revealed binding sites for lactose with different affinities, while the galectin-8 binds preferentially to larger glycans such as glycosphingolipids ([@B122]; [@B80]; [@B59]). The capacity of TR galectins to cross-link cells with different synthetic glycoconjugates ([@B122]; [@B52]) strongly suggests significant differences in the binding properties of their N- and C-CRDs. From the functional standpoint, the most striking example is the recognition and killing of *Escherichia coli* O86 that display B-blood group oligosaccharides (BGB+ *E. coli*) by the TR galectin-4 and -8. Mutation of key residues in either CRD revealed that the C-CRD mediates recognition the BGB+ *E. coli* but does not affect its viability, while the N-CRD was not affected, suggesting that N-CRD might be endowed with killing activity. This was confirmed by examining the binding and killing activity of the separate CRDs. This observation suggests that in galectin-4 and -8 the N- and C-CRDs not only have different recognition properties, but also they are functionally different in their interactions with the BGB+ *E. coli*([@B118]).

A different scenario is presented by the recognition of glycans on the phagocyte (self) and parasite (non-self) surface by the oyster galectin CvGal ([@B121]). Although the four CRDs of CvGal are not identical, homology modeling suggests that the minor differences in sequence among the CRDs do not result in significant differences in binding properties. Therefore, the cross-linking of similar glycans on the host phagocytic cells and on the surface of the parasite trophozoite by CRDs of similar binding properties can only be rationalized by the cross-linking of similar self and non-self glycans by the folding of the 4-CRD polypeptide in a particular geometry, such as a tetrahedral architecture, where the CRDs are oriented in opposite directions. A similar model could be proposed by single-CRD proto type and chimera galectins for which the requisite multivalency and the spatial arrangement and orientation of the CRDs is achieved by oligomerization of the single-CRD subunits. However, questions about the molecular and structural basis for recognition and binding to either similar or distinct self or non-self glycans remain open, and several aspects concerning the protein, the carbohydrate ligands, the thermodynamics of lectin--ligand interaction, and the particular microenvironment in which this interaction takes place merit further discussion. With regards to the protein, recognition specificity and affinity are key aspects of the lectin--ligand interaction(s) that modulate downstream effector functions.

In addition to the structural aspects of the primary and extended carbohydrate binding sites by any CRD in monovalent recognition, multiple factors contribute to the energetics of the interaction, which are further complicated when addressing multivalent recognition ([@B52]). Although as discussed above for C-, and F-lectins and TR galectins multivalency is a property of tandemly arrayed CRDs in the lectin polypeptide subunit, oligomerization of the monomers results in displays of clustered binding sites that either in their geometry or dimensions can be unique to a particular lectin. For example, the "bouquet"-like display of binding sites in the MBL trimer results in multivalency for sugars spaced about 45 Å apart, and increases avidity of the binding ([@B100]). Although a similar CRD display is presented in F-type lectins, the geometry of the ligand display requires sugars spaced 26 Å apart ([@B10], [@B11]). The tissue localization and subcellular compartmentalization of lectins can influence their oligomerization and in turn, influence the selective binding of lectins to particular ligands. For galectins, oligomerization and clustering of CRDs enables binding to and cross-linking of multivalent glycoproteins and glycolipids on the cell surface leading to formation of microdomains and lattices that signal vial specific pathways depending on the glycans and galectins involved ([@B44]; [@B99]; [@B131]). In addition, the redox properties of the intracellular and extracellular environments can modulate the activity of lectin--ligand interactions, and the biological outcome. Most galectins are active in the reducing environment, but are susceptible to inactivation by oxidation of their free Cys residues present in the CRD ([@B118]). In the reducing intracellular environment, galectins remain stable, but upon secretion to the mostly oxidative extracellular space, the oxidation of the free cysteines compromises not only the binding activity but also the oligomerization of the galectin subunits ([@B118]). It is noteworthy that the binding of galectin-9 to the protein disulfide isomerase at the cell surface, increases retention of the enzyme which in turn modulates the redox status at the plasma membrane ([@B99]). In addition to the lectin quaternary structure as established via structural or hydrodynamic approaches, higher orders of aggregation may occur in environments where the lectin concentration reaches above a certain threshold. The galactosyl-binding lectins DCL-I and DCL-II from the protochordate *Didemnum candidum* behave as homotetramers of 14.5 and 15.5 kDa subunits, respectively, as revealed by sedimentation velocity and sedimentation equilibrium studies. However, even at concentrations below 1 mg/ml, a positive dependence of the sedimentation coefficient with protein concentration was observed, suggesting that at increasing concentrations the protein associates at orders above the tetramer ([@B128]). For the dimeric galectin-1, further association to form tetramers is temperature driven ([@B28]). Furthermore, the ligand density at the cell surface can drive oligomerization of the lectins subunits. In solution, galectin-3 monomers are in equilibrium with higher order oligomers, and when binding to multivalent glycoproteins or cell surface glycans they may recruit additional monomers to form a complex of multivalent interactions via galectin-3 trimers and pentamers ([@B1]). The density of the carbohydrate ligands and their protein or lipid scaffolding context on the cell surface are key factors that determine lectin recognition and affinity. As proposed by [@B28], in contrast to the well-defined dissociation constants that describe the binding of lectin monomers to monovalent glycans, a wide range of relative dissociation constants is needed to describe lectin binding to multivalent surface glycans, that depends on the density and number of glycans on a surface and increased negative cooperativity. The authors propose that this relative affinity should replace the term avidity ([@B13]). Galectin binding to ligand is enthalpically driven, exhibits enthalpy-entropy compensation, and follows a van't Hoff dependence of the binding constant on temperature, properties that are shared by other lectins. Further, the solvation properties of the CRD, the reorganization or displacement of the water shell, and the establishment of defined water-mediated interactions between the protein and the carbohydrate are factors that affect the thermodynamic aspects of the recognition process and stability of the lectin--ligand interaction ([@B29]; [@B27]; [@B32]). As discussed above, many functional properties of lectins such as the triggering of signaling cascades result from clustered CRDs recognizing multivalent carbohydrate moieties in different scaffolds exposed at the cell surface, followed by the formation of microdomains and lattices ([@B99]). Therefore, a detailed knowledge of the thermodynamic aspects of lectin-mediated cross-linking of complex glycans is critical for the understanding of lectin-mediated selective recognition of self and non-self ligands. In this regard, recent studies have shown that high-affinity lectin--mucin interactions are driven by favorable binding entropy of binding associated with a "bind and jump" mechanism. This consists of a dynamic binding process in which the bound lectins jump from carbohydrate to carbohydrate moiety in the multivalent glycans, which by enhancing entropic effects facilitates binding and subsequent complex formation ([@B28]). The factors discussed above suggest that in the natural context, multiple factors that concern the protein binding site and lectin oligomerization, the display geometry and density of the recognized carbohydrate moieties in a particular protein or lipid scaffold, and the particular properties of the environment where the lectin--sugar interaction takes place, may determine not only the binding dynamics and affinity, but also the lectin's preference for any one of the (self or non-self) ligands available.

GALECTINS AS RECEPTORS FOR MICROBIAL ADHESION AND INFECTION
===========================================================

Whether galectin-mediated recognition is an effective defence mechanism with a clear benefit for the host is not entirely clear, except for a few examples discussed above ([@B15]; [@B23]; [@B58]; [@B117]). In some cases, however, the microbe's recognition by the vector or host galectins promotes its adhesion, host cell entry, or infection persistence, in addition to modulating the host's immune responses. Thus, these pathogens and parasites would "subvert" the roles of host or vector galectins as PRRs, to attach to or gain entry into their cells. This is clearly illustrated by the participation of galectin interactions in the infection mechanisms of HIV. In contrast to the inhibitory role of galectin-1 in paramixovirus-mediated cell fusion, galectin-1, which is abundant in organs that represent major reservoirs for HIV-1, such as the thymus and lymph nodes, promotes infection by HIV-1 by facilitating viral attachment to CD4 receptor, and increasing infection efficiency ([@B86]; [@B76]). Recent studies showed that galectin-1 enhances HIV adsorption kinetics on monocyte-derived host macrophages, which facilitates HIV-1 infectivity by shortening the time required to establish an infection. Further, galectin-1 would also function as a soluble scavenger receptor and enhance the uptake of the virus by macrophages, which together with evidence that galectin-1 is present in the ejaculate and the heads and tails of late spermatids, led to extend the proposal that galectin-1 may also facilitate sexual transmission of HIV-1 ([@B76]). This would take place through enhancement of viral adsorption kinetics on the target cells' surface by the galectin-1 released by sheared fibroblasts and epithelial cells following sex-related microabrasions. Gal-3 has no effect on HIV-1 adsorption, entry, or infection, although its expression is upregulated by the HIV Tat protein in several human cell lines, and in cells infected with other retroviruses, suggesting that it may participate in regulation of antiviral immunity ([@B107]; [@B50]; [@B36]). This underscores the relevance of the subtle differences in galectin specificity and affinity that may determine very different recognition and effector outcomes. It is noteworthy that HIV also uses recognition by DC-SIGN, a C-type lectin, to enter DCs, thereby underscoring the multiple adaptations of the viral glycome for host infection ([@B47]; [@B124]).

Several *Leishmania* species, which spend part of their life cycle in phlebotomine sandflies that constitute vectors for transmission to the vertebrate hosts, are also illustrative examples. Upon the sandfly feeding on blood from an infected host, the ingested amastigotes mature into promastigotes, which attach to the insect midgut epithelium to prevent their excretion along with the digested bloodmeal, and undergo numerous divisions before differentiating into free-swimming infective metacyclics ([@B132]). Although the involvement of the parasite LPG in this interaction had been suspected from prior studies, the specific *Phlebotomus papatasi* sandfly midgut receptor for the procyclic *L. major* LPG was identified as a 35.4-kDa TR galectin (PpGalec) only expressed by epithelial midgut cells, and upregulated in the blood-feeding females ([@B79]). Because the binding specificity of PpGalec is restricted to *Leishmania* promastigotes bearing poly-Gal (β1--3) side chains on their LPG, it was proposed that it is the carbohydrate moiety responsible for specific binding of *L. major* to *P. papatasi* midgut linings. The assembly of polygalactose epitopes is downregulated during *L. major* metacyclogenesis, and thus, unable to bind to rPpGalec the free-swimming infective metacyclic promastigotes are released from the midgut for transmission from the sandfly to the mammalian host ([@B79]).

The protozoan parasite *Perkinsus marinus* is a facultative intracellular parasite that causes "Dermo" disease in the eastern oyster *Crassostrea virginica*, and is responsible for catastrophic damage to shellfisheries and the estuarine environment in North America ([@B91]). The infection mechanism remains unclear, but it is likely that while filter feeding, the healthy oysters ingest *P. marinus* trophozoites released to the water column by the infected neighboring individuals. Inside oyster phagocytic cells (hemocytes), trophozoites resist oxidative killing, proliferate, and spread throughout the host. It was recently discovered that oyster hemocytes recognize *P. marinus* via a novel galectin (CvGal) that displays four canonical galectin CRDs, a domain organization unlike any of the known galectin types ([@B121]). Two amino acid residues (His^53^ and Asp^55^) that interact with the NAc group via a water molecule are missing in all four CvGal CRDs resulting in broader carbohydrate specificity. CvGal is present in the cytoplasm of circulating granulocytes, and upon their attachment and spreading it is translocated to the periphery, secreted, and binds to the cell surface. The remaining galectin is released to the extracellular environment, where it may bind to all other circulating (non-activated) granulocytes and hyalinocytes. The most surprising observation, however, was that the soluble CvGal also binds in a carbohydrate-specific manner to a wide variety of microorganisms, phytoplankton components, and preferentially, to *Perkinsus* spp. trophozoites, suggesting a direct role in recognition and opsonization of potential microbial pathogens, as well as algal food. The partial inhibition of phagocytosis of *P. marinus* trophozoites by pre-treatment of hemocytes with anti-CvGal revealed that the hemocyte surface-associated CvGal is a phagocytosis receptor for *P. marinus*. Thus, *P. marinus* may have evolved to adapt the trophozoite's glycocalyx to be selectively recognized by the oyster hemocyte CvGal, thereby subverting the oyster's innate immune/feeding recognition mechanism to gain entry into the host cells ([@B121]). A galectin of similar domain organization was recently identified in the snail *Biomphalaria glabrata*, the intermediate host of the human blood fluke *Schistosoma mansoni*, and was proposed to mediate interactions with the parasite ([@B140]).

A recent study identified galectin-1 as the receptor for the protozoan parasite *Trichomonas vaginalis* ([@B85]) the causative agent of the most prevalent non-viral sexually transmitted human infection in both women and men. As an obligate extracellular parasite, establishment and persistence of *T. vaginalis* infection requires adherence to the host epithelial cell surface. Like *Leishmania* spp., *T. vaginalis* displays a surface LPG rich in galactose and *N*-acetyl glucosamine, which is recognized in a carbohydrate-dependent manner by galectin-1 expressed by the epithelial cells in the cervical linings, as well as placenta, prostate, endometrial, and decidual tissue, also colonized by the parasite ([@B85]).

CONCLUSION
==========

By recognizing highly conserved and widely distributed microbial surface glycans (PAMPs or MAMPs) which are essential for the microbe but absent in the host, lectins like the MBL, a member of the C-type lectin family, fit accurately the definition of PRR. Recent studies clearly indicate that also galectins can function as PRRs that target oligosaccharides on the surface of virus, bacteria, protista and helminth pathogens, and parasites. A perplexing paradox arises, however, by the fact that galectins also recognize endogenous lactosamine-containing glycans on the host cell surface during development and regulation of immune homeostasis. For the TR-type galectins that display two CRDs of similar but distinct specificity in a single polypeptide monomer, the binding and cross-linking of endogenous and exogenous glycans can be rationalized by the distinct properties of their N- and C-terminus binding sites. For other lectins such as the proto- and chimera-type galectins that display a single CRD per monomer, their capacity to recognize both endogenous and exogenous glycans through the same binding site, can be explained by taking into consideration the multiple factors pertaining to the local lectin concentrations and oligomerization, the geometry of the presentation of the multivalent carbohydrate ligands on the host or microbial cell surface, and the properties of the microenvironment in which interactions take place. For example, in a local microenvironment where an infection is initiated, the particular concentration of galectins released to the extracellular space may lead to a distinctive oligomerization, CRD display geometry, and avidity that may shift galectin binding from the endogenous ligands to the glycans displayed on the microbial surface in a particular architectural presentation. It has been proposed that both the microbial and host glycomes and their receptors continuously evolve to escape mutual recognition, a process known as the "Red Queen effect" (reviewed in [@B125]), by which the microbe avoids recognition by the host innate immune receptors (PRRs) and, the host by the microbial colonization factors (agglutinins, adhesins, and lectins). Given the key roles played by galectins in early development and regulation of immune homeostasis by the recognition of "self" glycans, strong functional constraints would prevent galectins from significant evolutionary changes in carbohydrate specificity. This is supported by the considerable structural conservation within this lectin family. Further, with the current evidence about how pathogens and parasites, which display a remarkable evolutionary plasticity, efficiently subvert the roles of galectins to attach or gain entrance into the host cells, it seems more plausible that instead of avoiding recognition by the host, they would have evolved their glycomes to mimic their hosts' in a "Trojan horse" model (reviewed in [@B125]), and rely on the host's self-recognition molecules such as galectins for attachment to the vector or host invasion. It is noteworthy that most of (if not all) these pathogens and parasites are endowed with diverse and powerful mechanisms to evade intracellular killing by the host, and/or downregulate downstream immune responses. The complex strategies such as glycan mimicry developed by symbionts, commensals, and microbial pathogens to successfully colonize, enter, proliferate, and disseminate within and among their hosts or vectors, are the products of strong selective pressures that have led to adaptations that ensure their survival in the most hostile environment of all ([@B16]; [@B51]). Thus, these fine tuned protein--carbohydrate interactions represent a significant challenge for the development of innovative strategies for intervention in infectious disease.
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